Literature DB >> 32479651

Hypomethylation of Notch1 DNA is associated with the occurrence of uveitis.

H Wei1, X Yin1, H Tang1, Y Gao2, B Liu3, Q Wu4, Q Tian4, Y Hao1, H Bi2, D Guo2.   

Abstract

Uveitis is a serious intra-ocular inflammatory disease that can lead to visual impairment even blindness worldwide. Notch signaling can regulate the differentiation of naive CD4+ T cells, influencing the development of uveitis. DNA methylation is closely related to the autoimmune diseases. In this study, we measured the Notch1 DNA methylation level, determined the Notch1 and related DNA methylases mRNA expression and evaluated the ratio of T helper type 17 regulatory T cell (Th17/Treg ) in peripheral blood mononuclear cells (PBMCs) from uveitis patients and normal control subjects; we also tested the levels of relevant inflammatory cytokines in serum from the participants. Results indicated that compared with those in normal control individuals, the expression of ten-eleven translocation 2 (TET2) and Notch1 mRNA is elevated in uveitis patients, whereas the methylation level in Notch1 DNA promotor region [-842 ~ -646 base pairs (bp)] is down-regulated, and is unrelated to anatomical location. Moreover, the Th17/Treg ratio is up-regulated in PBMCs from uveitis patients, accompanied by the elevated levels of proinflammatory cytokines [e.g. interleukin (IL)-2, IL-6, IL-17 and interferon (IFN)-γ] in serum from uveitis patients. These findings suggest that the over-expression of TET2 DNA demethylase may lead to hypomethylation of Notch1, activate the Notch1 signaling, induce naive CD4+ T cells to differentiate theTh17 subset and thus disturb the balance of the Th17/Treg ratio in uveitis patients. Overall, hypomethylation of Notch1 DNA is closely associated with the occurrence of uveitis. Our study preliminarily reveals the underlying mechanism for the occurrence of uveitis related to the hypomethylation of Notch1 DNA, providing a novel therapeutic strategy against uveitis in clinical practice.
© 2020 British Society for Immunology.

Entities:  

Keywords:  Notch1; Th17; Treg; hypomethylation; uveitis

Year:  2020        PMID: 32479651      PMCID: PMC7419911          DOI: 10.1111/cei.13471

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

Review 1.  Notch signaling: cell fate control and signal integration in development.

Authors:  S Artavanis-Tsakonas; M D Rand; R J Lake
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  Proteomic Profiling Analysis Reveals a Link between Experimental Autoimmune Uveitis and Complement Activation in Rats.

Authors:  D D Guo; B Hu; H Y Tang; Y Y Sun; B Liu; Q M Tian; H S Bi
Journal:  Scand J Immunol       Date:  2017-05       Impact factor: 3.487

3.  Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy.

Authors:  Jonas J W Kuiper; Tuna Mutis; Wilco de Jager; Jolanda D F de Groot-Mijnes; Aniki Rothova
Journal:  Am J Ophthalmol       Date:  2011-05-13       Impact factor: 5.258

4.  Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

Authors:  Clara Dees; Pawel Zerr; Michal Tomcik; Christian Beyer; Angelika Horn; Alfiya Akhmetshina; Katrin Palumbo; Nicole Reich; Jochen Zwerina; Michael Sticherling; Mark P Mattson; Oliver Distler; Georg Schett; Jörg H W Distler
Journal:  Arthritis Rheum       Date:  2011-05

5.  Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.

Authors:  K Gocho; I Kondo; K Yamaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

6.  Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

Authors:  Wei Chi; Xuefei Zhu; Peizeng Yang; Xiaoli Liu; Xiaomin Lin; Hongyan Zhou; Xiangkun Huang; Aize Kijlstra
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

7.  cAMP-responsive element modulator α (CREMα) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE).

Authors:  Thomas Rauen; Alexandros P Grammatikos; Christian M Hedrich; Jürgen Floege; Klaus Tenbrock; Kim Ohl; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2012-11-02       Impact factor: 5.157

8.  TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.

Authors:  R Calabrese; E Valentini; F Ciccarone; T Guastafierro; M G Bacalini; V A G Ricigliano; M Zampieri; V Annibali; R Mechelli; C Franceschi; M Salvetti; P Caiafa
Journal:  Biochim Biophys Acta       Date:  2014-04-13

Review 9.  DNA methylation perspectives in the pathogenesis of autoimmune diseases.

Authors:  Bao Sun; Lei Hu; Zhi-Ying Luo; Xiao-Ping Chen; Hong-Hao Zhou; Wei Zhang
Journal:  Clin Immunol       Date:  2016-01-25       Impact factor: 3.969

Review 10.  Notch regulation of lymphocyte development and function.

Authors:  Freddy Radtke; Anne Wilson; Stephane J C Mancini; H Robson MacDonald
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

View more
  2 in total

Review 1.  The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH.

Authors:  Ryan J Dashek; Connor Diaz; Bysani Chandrasekar; R Scott Rector
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

2.  SIRT6 Promotes Osteogenic Differentiation of Adipose-Derived Mesenchymal Stem Cells Through Antagonizing DNMT1.

Authors:  Bo Jia; Jun Chen; Qin Wang; Xiang Sun; Jiusong Han; Fernando Guastaldi; Shijian Xiang; Qingsong Ye; Yan He
Journal:  Front Cell Dev Biol       Date:  2021-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.